Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: Chondromodulin-I and tenomodulin

Connective Tissue Research

Volumn 46, Issue 1, 2005, Pages 3-11

  Hiraki, Yuji ^a   Shukunami, Chisa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antiangiogenic barrier; Avascular mesenchyme; Cartilage; Chondromodulin I; Tenomodulin

Indexed keywords

ADENOVIRUS VECTOR; AGGRECAN; ANGIOGENESIS INHIBITOR; CARDIOVASCULAR AGENT; CHONDROMODULIN 1; COLLAGEN TYPE 2; COMPLEMENTARY DNA; DNA; FIBROBLAST GROWTH FACTOR 2; PIGMENT EPITHELIUM DERIVED FACTOR; RECOMBINANT CHONDROMODULIN 1; TENOMODULIN; UNCLASSIFIED DRUG; VASCULOTROPIN; CHONDROCYTE GROWTH FACTORS; MEMBRANE PROTEIN; PROTEIN;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BASEMENT MEMBRANE; BONE REMODELING; CARBOXY TERMINAL SEQUENCE; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CORNEA; DNA SYNTHESIS; DRUG STRUCTURE; ENCHONDRAL OSSIFICATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE MAPPING; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; LIGAMENT; MESENCHYME; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN ISOLATION; REVIEW; TENDON; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; MESODERM; METABOLISM;

ADENOVIRIDAE;

ANGIOGENESIS INHIBITORS; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MESODERM; PROTEINS;

EID: 20444436373     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008200590935547     Document Type: Review

References (44)

1. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9:653-660.
2. Ferrara, N., Gerber, H.P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9:669-676.
3. Ferrara, N., Hillan, K.J., Gerber, H.P., and Novotny, W. (2004). Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3:391-400.
4. Kalluri, R. (2003). Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3:422-433.
5. Iruela-Arispe, M.L., Luque, A., and Lee, N. (2004). Thrombospondin modules and angiogenesis. Int. J. Biochem. Cell Biol. 36:1070-1078.
6. D'Amore, P.A., and Ng, Y.S. (2002). Tales of the cryptic: unveiling more angiogenesis inhibitors. Trends Mol. Med. 8:313-315.
7. Eisenstein, R., Sorgente, N., Soble, L.W., Miller, A., and Kuettner, K.E. (1973). The resistance of certain tissues to invasion: Penetrability of explanted tissues by vascularized mesenchyme. Am. J. Pathol. 73:765-774.
8. Sorgente, N., Kuettner, K.E., Soble, L.W., and Eisenstein, R. (1975). The resistance of certain tissues to invasion: II. Evidence for extractable factors in cartilage which inhibit invasion by vascularized mesenchyme. Lab. Invest. 32:217-222.
9. Langer, R., Brem, H., Falterman, K., Klein, M., and Folkman, J. (1976). Isolations of a cartilage factor that inhibits tumor neovascularization. Science 193:70-72.
10. Boivin, D., Gendron, S., Beaulieu, E., Gingras, D., and Beliveau, R. (2002). The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis. Mol. Cancer Ther. 1:795-802.
11. Moses, M.A., Sudhalter, J., and Langer, R. (1992). Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes. J. Cell Biol. 119:475-482.
12. Ohba, Y., Goto, Y., Kimura, Y., Suzuki, F., Hisa, T., Takahashi, K., and Takigawa, M. (1995). Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8. Biochim. Biophys. Acta 1245:1-8.
13. Moses, M.A., Wiederschain, D., Wu, I., Fernandez, C.A., Ghazizadeh, V., Lane, W.S., Flynn, E., Sytkowski, A., Tho, T., and Langer, R. (1999). Troponin I is present in human cartilage and inhibits angiogenesis. Proc. Natl. Acad. Sci. USA 96:2645-2650.
14. Liu, N., Lapcevich, R.K., Underhill, C.B., Han, Z., Gao, F., Swartz, G., Plum, S.M., Zhang, L., and Green, S.J. (2001). Metastatin: A hyaluronan-binding complex from cartilage that inhibits tumor growth. Cancer Res. 61:1022-1028.
15. Hiraki, Y., Tanaka, H., Inoue, H., Kondo, J., Kamizono, A., and Suzuki, F. (1991). Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem. Biophys. Res. Commn. 175:971-977.
16. Hiraki, Y., Inoue, H., Iyama, K., Kamizono, A., Ochiai, M., Shukunami, C., Iijima, S., Suzuki, F., and Kondo, J. (1997). Identification of chondromodulin I as a novel endothelial cell growth inhibitor: Purification and its localization in the avascular zone of epiphyseal cartilage. J. Biol. Chem. 272:32419-32426.
17. Shukunami, C., Oshima, Y., and Hiraki, Y. (2001). Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem. Biophys. Res. Comm. 280:1323-1327.
18. Yanagihara, I., Yamagata, M., Sakai, N., Shukunami, C., Kurahashi, H., Yamazaki, M., Michigami, T., Hiraki, Y., and Ozono, K. (2000). Genomic organization of the human chondromodulin-1 gene containing a promoter region that confers the expression of reporter gene in chondrogenic ATDC5 cells [in process citation]. J. Bone Miner. Res. 15:421-429.
19. Sachdev, S.W., Dietz, U.H., Oshima, Y., Lang, M.R., Knapik, E.W., Hiraki, Y., and Shukunami, C. (2001). Sequence analysis of zebrafish chondromodulin-1 and expression profile in the notochord and chondrogenic regions during cartilage morphogenesis. Mech. Dev. 105:157-162.
20. Shukunami, C., Iyama, K., Inoue, H., and Hiraki, Y. (1999). Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int. J. Dev. Biol. 43:39-49.
21. Hiraki, Y., Mitsui, K., Endo, N., Takahashi, K., Hayami, T., Inoue, H., Shukunami, C., Tokunaga, K., Kono, T., Yamada, M., Takahashi, H.E., and Kondo, J. (1999). Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells. Eur. J. Biochem. 260:869-878.
22. Dietz, U.H., Ziegelmeier, G., Bittner, K., Bruckner, P., and Balling, R. (1999). Spatio-temporal distribution of chondromodulin-I mRNA in the chicken embryo: expression during cartilage development and formation of the heart and eye. Dev. Dyn. 216:233-243.
23. Shukunami, C., Yamamoto, S., Tanabe, T., and Hiraki, Y. (1999). Generation of multiple transcripts from the chicken chondromodulin-I gene and their expression during embryonic development. FEBS Lett. 456:165-170.
24. Yamana, K., Wada, H., Takahashi, Y., Sato, H., Kasahara, Y., and Kiyoki, M. (2001). Molecular cloning and characterization of CHM1L, a novel membrane molecule similar to chondromodulin-I. Biochem. Biophys. Res. Comm. 280:1101-1106.
25. Brandau, O., Meindl, A., Fassler, R., and Aszodi, A. (2001). A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev. Dyn. 221:72-80.
26. Azizan, A., Holaday, N., and Neame, P.J. (2001). Post-translational processing of bovine chondromodulin-I. J. Biol. Chem. 276:23632-23638.
27. Oshima, Y., Sato, K., Tashiro, F., Miyazaki, J., Nishida, K., Hiraki, Y., Tano, Y., and Shukunami, C. (2004). Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J. Cell Sci. 117:2731-2744.
28. Sanchez-Pulido, L., Devos, D., and Valencia, A. (2002). BRICHOS: A conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem. Sci. 27:329-332.
29. D'Amore, P.A. (1994). Mechanisms of retinal and choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 35:3974-3979.
30. Imanishi, J., Kamiyama, K., Iguchi, I., Kita, M., Sotozono, C., and Kinoshita, S. (2000). Growth factors: Importance in wound healing and maintenance of transparency of the cornea. Prog. Retin Eye. Res. 19:113-129.
31. Dawson, D.W., Volpert, O.V., Gillis, P., Crawford, S.E., Xu, H., Benedict, W., and Bouck, N.P. (1999). Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 285:245-248.
32. Miyajima-Uchida, H., Hayashi, H., Beppu, R., Kuroki, M., Fukami, M., Arakawa, F., Tomita, Y., and Oshima, K. (2000). Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 41:561-567.
33. Funaki, H., Sawaguchi, S., Yaoeda, K., Koyama, Y., Yaoita, E., Funaki, S., Shirakashi, M., Oshima, Y., Shukunami, C., Hiraki, Y., Abe, H., and Yamamoto, T. (2001). Expression and localization of angiogenic inhibitory factor, chondromodulin-I, in adult rat eye. Invest. Ophthalmol. Vis. Sci. 42:1193-1200.
34. Oshima, Y., Shukunami, C., Honda, J., Nishida, K., Tashiro, F., Miyazaki, J., Hiraki, Y., and Tano, Y. (2003). Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest. Ophthalmol. Vis. Sci. 44:1814-1823.
35. Inoue, H., Kondo, J., Koike, T., Shukunami, C., and Hiraki, Y. (1997). Identification of an autocrine chondrocyte colony-stimulating factor: chondromodulin-I stimulates the colony formation of growth plate chondrocytes in agarose culture. Biochem. Biophys. Res. Comm. 241:395-400.
36. Hayami, T., Shukunami, C., Mitsui, K., Endo, N., Tokunaga, K., Kondo, J., Takahashi, H.E., and Hiraki, Y. (1999). Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett. 458:436-440.
37. Furumatsu, T., Nishida, K., Kawai, A., Namba, M., Inoue, H., and Ninomiya, Y. (2002). Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth. Int. J. Cancer 97:313-322.
38. Nakamichi, Y., Shukunami, C., Yamada, T., Aihara, K., Kawano, H., Sato, T., Nishizaki, Y., Yamamoto, Y., Shindo, M., Yoshimura, K., Nakamura, T., Takahashi, N., Kawaguchi, H., Hiraki, Y., and Kato, S. (2003). Chondromodulin I is a bone remodeling factor. Mol. Cell. Biol. 23:636-644.
39. Mori, Y., Hiraki, Y., Shukunami, C., Kakudo, S., Shiokawa, M., Kagoshima, M., Mano, H., Hakeda, Y., Kurokawa, T., Suzuki, F., and Kumegawa, M. (1997). Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chondromodulin-I and -II. FEBS Lett. 406:310-314.
40. Kusafuka, K., Hiraki, Y., Shukunami, C., Yamaguchi, A., Kayano, T., and Takemura, T. (2001). Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: Immunohistochemical analysis. Am. J. Pathol. 158:1465-1472.
41. Aoyama, T., Okamoto, T., Nagayama, S., Nishijo, K., Ishibe, T., Yasura, K., Tsuboyama, T., Nakayama, T., Nakashima, Y., Nakamura, T., and Toguchida, J. (2004). Expression of the chondromodulin-I gene in chondrosarcomas. Cancer Lett. 204:61-68.
42. Aoyama, T., Okamoto, T., Nagayama, S., Nishijo, K., Ishibe, T., Yasura, K., Nakayama, T., Nakamura, T., and Toguchida, J. (2004). Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3. J. Biol. Chem. 279:28789-28797.
43. Jain, S., Watson, M.A., DeBenedetti, M.K., Hiraki, Y., Moley, J.F., and Milbrandt, J. (2004). Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors. Cancer Res. 64:3907-3913.
44. Setoguchi, K., Misaki, Y., Kawahata, K., Shimada, K., Juji, T., Tanaka, S., Oda, H., Shukunami, C., Nishizaki, Y., Hiraki, Y., and Yamamoto, K. (2004). Suppression of T cell responses by chondromodulin I, a cartilage-derived angiogenesis inhibitory factor: therapeutic potential in rheumatoid arthritis. Arth. Rheum. 50:828-839.